IP Library Granted Patent US 10,092,615
Granted Patent B2
US 10,092,615 · App. 15/143,545 · Granted Oct 9, 2018

Nutritional supplements for improving male fertility

Inventor: Suzanne Munson (Bellingham, WA)
Assignee: Fairhaven Health, LLC
A61K36/87A23L1/296A23L1/30A23L1/302A23L1/3002A23L1/304A23L1/3051A23L33/10A23L33/15A23L33/16A23L33/175A61K31/01A61K31/07A61K31/122A61K31/197A61K31/198A61K31/205A61K31/355A61K31/375A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/525A61K31/593A61K31/714A61K33/00A61K33/04A61K33/18A61K33/24A61K33/30A61K33/32A61K33/34A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,092,615
App. No.
15/143,545
Granted
Oct 9, 2018
Kind
B2
Abstract

The present invention relates to a fertility-enhancing composition for human male fertility therapy and a method for using the same to improve or enhance human male fertility. The nutritional supplement composition of the invention includes an effective amount of L-carnitine, coenzyme Q10, vitamin B 12 , N-acetyl L-cysteine, and grape seed extract.

Claims (15)

1. A nutritional supplement composition for improving male fertility comprising an effective amount of L-carnitine, coenzyme Q10, Vitamin B 12 , N-acetyl L-cysteine, grape seed extract, biotin, molybdenum, and lycopene, wherein a single serving size of the composition contains at least about 25 mg of molybdenum.

2. The nutritional supplement composition of claim 1 , wherein a single unit of said composition further comprises lycopene.

3. The nutritional supplement composition of claim 1 , wherein a single unit of said composition further comprises an antioxidant, vitamins, minerals or a combination thereof.

4. The nutritional supplement composition of claim 1 , wherein L-carnitine is L-carnitine tartrate, and wherein the ratio of L-carnitine tartrate to coenzyme Q10 in a single unit is at least about 5:1.

5. The nutritional supplement composition of claim 1 , wherein the ratio of L-carnitine tartrate to N-acetyl L-cysteine in a single unit is at least about 5:1.

6. The nutritional supplement composition of claim 1 , wherein L-carnitine is present as L-carnitine tartrate.

7. The nutritional supplement composition of claim 6 , wherein the ratio of L-carnitine tartrate to vitamin B 12 in a single unit is at least about 1:1.

8. The nutritional supplement composition of claim 1 , wherein a single unit of said composition comprises at least 25 mg of N-acetyl L-cysteine.

9. The nutritional supplement composition of claim 1 , wherein a single serving of said composition comprises at least 100 mg of N-acetyl L-cysteine.

10. The nutritional supplement composition of claim 1 further comprising selenium, zinc, copper, manganese, chromium, or a combination thereof.

11. The nutritional supplement composition of claim 1 further comprising vitamin A, vitamin C, vitamin D3, vitamin E, vitamin K, thiamin, riboflavin, niacin, vitamin B 6 , QUATREFOLIC® (glucosamine salt of (6S)-5-methyltetrahydrofolate), pantothenic acid, iodine, or a combination thereof.

12. The nutritional supplement composition of claim 1 further comprising L-arginine.

13. A method for improving fertility in a male human comprising administering to said male human an effective amount of a composition of claim 1 .

14. The method of claim 13 , wherein said composition is administered one to three unit dosage formulation per day to said male human.

15. The method of claim 13 , wherein said composition is administered to said male human for at least 3 months.

Assignments (3)
SECURITY INTEREST Recorded Apr 22, 2022
From: FAIRHAVEN HEALTH, L.L.C.
To: BALANCE POINT CAPITAL PARTNERS V, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 059678/0111 →
SECURITY INTEREST Recorded Apr 21, 2022
From: FAIRHAVEN HEALTH, L.L.C.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 059671/0774 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: MUNSON, SUZANNE
To: FAIRHAVEN HEALTH, LLC
Reel/Frame 038554/0819 →
Continuity (1)
Related Publication 20170312328A1 · Nov 2, 2017